OSI Pharmaceuticals moving to Westchester Co., N.Y. Merck, Portola to collaborate to develop stroke treatment Rexahn Pharmaceuticals regains compliance with NYSE King Pharmaceuticals to resubmit Remoxy application to FDA FDA approves Alimta as maintenance therapy for advanced lung cancer FDA rejects biotech co.’s non-Hodgkin’s lymphoma treatment Biogen Idec, Acorda Therapeutics to develop, commercialize MS drug BioSante, Cell Genesys to merge Bayer, Celera to develop cancer drugs Merck KGaA launches RebiSmart First Previous 236 237 238 Next Last